{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T10:46:26Z","timestamp":1782557186033,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFA1800902"],"award-info":[{"award-number":["2023YFA1800902"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370366"],"award-info":[{"award-number":["82370366"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570426"],"award-info":[{"award-number":["82570426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yunnan Provincial Academician and Expert Workstation Project","award":["202605AF350065"],"award-info":[{"award-number":["202605AF350065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00204-026-04352-9","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:34:45Z","timestamp":1774949685000},"page":"2919-2940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CYP2C19 as a key enzyme in the metabolism of cantharidin in Huh-7 cells and mice"],"prefix":"10.1007","volume":"100","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing K.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8437-5998","authenticated-orcid":false,"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"4352_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154231","volume":"103","author":"P An","year":"2022","unstructured":"An P, Lu D, Zhang L, Lan H, Yang H, Ge G, Liu W, Shen W, Ding X, Tang D, Zhang W, Luan X, Cheng H, Zhang H (2022) Synergistic antitumor effects of compound-composed optimal formula from Aidi injection on hepatocellular carcinoma and colorectal cancer. Phytomedicine 103:154231. https:\/\/doi.org\/10.1016\/j.phymed.2022.154231","journal-title":"Phytomedicine"},{"issue":"9","key":"4352_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/00008571-200212000-00004","volume":"12","author":"J Blaisdell","year":"2002","unstructured":"Blaisdell J, Mohrenweiser H, Jackson J, Ferguson S, Coulter S, Chanas B, Xi T, Ghanayem B, Goldstein JA (2002) Identification and functional characterization of new potentially defective alleles of human CYP2C19. Pharmacogenetics 12(9):703\u2013711. https:\/\/doi.org\/10.1097\/00008571-200212000-00004","journal-title":"Pharmacogenetics"},{"issue":"1","key":"4352_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1124\/jpet.123.001772","volume":"388","author":"A Bryan","year":"2024","unstructured":"Bryan A, Pingali P, Faber A, Landry J, Akakpo JY, Jaeschke H, Li H, Lee WS, May L, Patel B, Neuwelt A (2024) High-dose acetaminophen with concurrent CYP2E1 inhibition has profound anticancer activity without liver toxicity. J Pharmacol Exp Ther 388(1):209\u2013217. https:\/\/doi.org\/10.1124\/jpet.123.001772","journal-title":"J Pharmacol Exp Ther"},{"key":"4352_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.125.052167","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jiang L, Gao Y, Chen W, Yan H, Wang T, Yang Y, Yao D, Liu D, Pan Y, Wang Y (2025) CYP2C19 genotype and efficacy of clopidogrel initiated between 24 to 72 hours for ischemic stroke. Stroke. https:\/\/doi.org\/10.1161\/STROKEAHA.125.052167","journal-title":"Stroke"},{"issue":"7","key":"4352_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/jat\/33.7.384","volume":"33","author":"YJ Dang","year":"2009","unstructured":"Dang YJ, Zhu CY (2009) Determination of trace cantharidin in plasma and pharmacokinetic study in beagle dogs using gas chromatography-mass spectrometry. J Anal Toxicol 33(7):384\u2013388. https:\/\/doi.org\/10.1093\/jat\/33.7.384","journal-title":"J Anal Toxicol"},{"issue":"3","key":"4352_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/JCP.0b013e318058244d","volume":"27","author":"J de Leon","year":"2007","unstructured":"de Leon J (2007) The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19. J Clin Psychopharmacol 27(3):241\u2013245. https:\/\/doi.org\/10.1097\/JCP.0b013e318058244d","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"4352_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5172","volume":"35","author":"C Duan","year":"2021","unstructured":"Duan C, Cheng W, Chen Q, Li X, Zhang J (2021) Pharmacokinetics and tissue distribution of cantharidin after oral administration of aqueous extracts from Mylabris in rats. Biomed Chromatogr 35(10):e5172. https:\/\/doi.org\/10.1002\/bmc.5172","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"4352_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/CIRCRESAHA.118.314350","volume":"124","author":"M El Refaey","year":"2019","unstructured":"El Refaey M, Musa H, Murphy NP, Lubbers ER, Skaf M, Han M, Cavus O, Koenig SN, Wallace MJ, Gratz D, Bradley E, Alsina KM, Wehrens XHT, Hund TJ, Mohler PJ (2019) Protein phosphatase 2A regulates cardiac Na channels. Circ Res 124(5):737\u2013746. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.314350","journal-title":"Circ Res"},{"key":"4352_CR9","first-page":"21","volume":"6","author":"A Fleckenstein","year":"1975","unstructured":"Fleckenstein A, Kanke J, D\u00f6ring HJ, Leder O (1975) Key role of Ca in the production of noncoronarogenic myocardial necroses. Recent Adv Stud Cardiac Struct Metab 6:21\u201332","journal-title":"Recent Adv Stud Cardiac Struct Metab"},{"issue":"3","key":"4352_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1124\/dmd.110.035873","volume":"39","author":"L Guo","year":"2011","unstructured":"Guo L, Dial S, Shi L, Branham W, Liu J, Fang JL, Green B, Deng H, Kaput J, Ning B (2011) Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab Dispos 39(3):528\u2013538. https:\/\/doi.org\/10.1124\/dmd.110.035873","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"4352_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2133\/dmpk.23.412","volume":"23","author":"K Hagihara","year":"2008","unstructured":"Hagihara K, Nishiya Y, Kurihara A, Kazui M, Farid NA, Ikeda T (2008) Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine. Drug Metab Pharmacokinet 23(6):412\u2013420. https:\/\/doi.org\/10.2133\/dmpk.23.412","journal-title":"Drug Metab Pharmacokinet"},{"issue":"10","key":"4352_CR12","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.7150\/ijbs.51638","volume":"17","author":"S Hu","year":"2021","unstructured":"Hu S, Chang J, Ruan H, Zhi W, Wang X, Zhao F, Ma X, Sun X, Liang Q, Xu H, Wang Y, Yang Y (2021) Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p\/DKK3 axis to inactivate \u03b2-catenin nuclear translocation and LEF1 translation. Int J Biol Sci 17(10):2504\u20132522. https:\/\/doi.org\/10.7150\/ijbs.51638","journal-title":"Int J Biol Sci"},{"issue":"6","key":"4352_CR13","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701","journal-title":"Hepatology"},{"issue":"11","key":"4352_CR14","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1021\/jm0489713","volume":"48","author":"LE Korhonen","year":"2005","unstructured":"Korhonen LE, Rahnasto M, M\u00e4h\u00f6nen NJ, Wittekindt C, Poso A, Juvonen RO, Raunio H (2005) Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. J Med Chem 48(11):3808\u20133815. https:\/\/doi.org\/10.1021\/jm0489713","journal-title":"J Med Chem"},{"issue":"2","key":"4352_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.braindev.2014.04.003","volume":"37","author":"T Kouga","year":"2015","unstructured":"Kouga T, Shimbo H, Iai M, Yamashita S, Ishii A, Ihara Y, Hirose S, Yamakawa K, Osaka H (2015) Effect of CYP2C19 polymorphisms on stiripentol administration in Japanese cases of Dravet syndrome. Brain Dev 37(2):243\u2013249. https:\/\/doi.org\/10.1016\/j.braindev.2014.04.003","journal-title":"Brain Dev"},{"issue":"24","key":"4352_CR16","doi-asserted-by":"publisher","first-page":"11867","DOI":"10.1073\/pnas.89.24.11867","volume":"89","author":"YM Li","year":"1992","unstructured":"Li YM, Casida JE (1992) Cantharidin-binding protein: identification as protein phosphatase 2A. Proc Natl Acad Sci U S A 89(24):11867\u201311870. https:\/\/doi.org\/10.1073\/pnas.89.24.11867","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4352_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/tox.22273","volume":"32","author":"CC Li","year":"2017","unstructured":"Li CC, Yu FS, Fan MJ, Chen YY, Lien JC, Chou YC, Lu HF, Tang NY, Peng SF, Huang WW, Chung JG (2017) Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo. Environ Toxicol 32(3):723\u2013738. https:\/\/doi.org\/10.1002\/tox.22273","journal-title":"Environ Toxicol"},{"key":"4352_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00204-011-0733-y","volume":"86","author":"J Lin","year":"2012","unstructured":"Lin J, Schyschka L, M\u00fchl-Benninghaus R et al (2012) Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism. Arch Toxicol 86:87\u201395. https:\/\/doi.org\/10.1007\/s00204-011-0733-y","journal-title":"Arch Toxicol"},{"issue":"5","key":"4352_CR19","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.3892\/ol.2018.8141","volume":"15","author":"YP Liu","year":"2018","unstructured":"Liu YP, Li L, Xu L, Dai EN, Chen WD (2018) Cantharidin suppresses cell growth and migration, and activates autophagy in human non-small cell lung cancer cells. Oncol Lett 15(5):6527\u20136532. https:\/\/doi.org\/10.3892\/ol.2018.8141","journal-title":"Oncol Lett"},{"issue":"2","key":"4352_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0009-9236(96)90129-0","volume":"60","author":"JS Mainac","year":"1996","unstructured":"Mainac JS, Balian JD, Foxworth JW, Willsie SK, Daus JC, Owen R, Flockhart DA (1996) Determination of CYP2C19 phenotype in black Americans with omeprazole: correlation with genotype. Clin Pharmacol Ther 60(2):138\u2013144. https:\/\/doi.org\/10.1016\/S0009-9236(96)90129-0","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"4352_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00228-004-0825-1","volume":"60","author":"S Micuda","year":"2004","unstructured":"Micuda S, Mundlova L, Anzenbacherova E, Anzenbacher P, Chladek J, Fuksa L, Martinkova J (2004) Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions. Eur J Clin Pharmacol 60(8):583\u2013589. https:\/\/doi.org\/10.1007\/s00228-004-0825-1","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"4352_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archderm.137.10.1357","volume":"137","author":"L Moed","year":"2001","unstructured":"Moed L, Shwayder TA, Chang MW (2001) Cantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol 137(10):1357\u20131360. https:\/\/doi.org\/10.1001\/archderm.137.10.1357","journal-title":"Arch Dermatol"},{"issue":"3","key":"4352_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.clpt.6100482","volume":"84","author":"SP Myrand","year":"2008","unstructured":"Myrand SP, Sekiguchi K, Man MZ, Lin X, Tzeng RY, Teng CH, Hee B, Garrett M, Kikkawa H, Lin CY, Eddy SM, Dostalik J, Mount J, Azuma J, Fujio Y, Jang IJ, Shin SG, Bleavins MR, Williams JA, Paulauskis JD, Wilner KD (2008) Pharmacokinetics\/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations. Clin Pharmacol Ther 84(3):347\u2013361. https:\/\/doi.org\/10.1038\/sj.clpt.6100482","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"4352_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111286","volume":"9","author":"A Novotn\u00e1","year":"2014","unstructured":"Novotn\u00e1 A, Krasulov\u00e1 K, Barto\u0148kov\u00e1 I, Korho\u0148ov\u00e1 M, Bachleda P, Anzenbacher P, Dvo\u0159\u00e1k Z (2014) Dual effects of ketoconazole cis-enantiomers on CYP3A4 in human hepatocytes and HepG2 Cells. PLoS ONE 9(10):e111286. https:\/\/doi.org\/10.1371\/journal.pone.0111286","journal-title":"PLoS ONE"},{"issue":"1","key":"4352_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7150\/ijms.10263","volume":"12","author":"T Ota","year":"2015","unstructured":"Ota T, Kamada Y, Hayashida M, Iwao-Koizumi K, Murata S, Kinoshita K (2015) Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population. Int J Med Sci 12(1):78\u201382. https:\/\/doi.org\/10.7150\/ijms.10263","journal-title":"Int J Med Sci"},{"issue":"4","key":"4352_CR26","first-page":"539","volume":"16","author":"B Pajovic","year":"2012","unstructured":"Pajovic B, Radosavljevic M, Radunovic M, Radojevic N, Bjelogrlic B (2012) Arthropods and their products as aphrodisiacs\u2014review of literature. Eur Rev Med Pharmacol Sci 16(4):539\u2013547","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"14","key":"4352_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.041634","volume":"14","author":"RC Patel","year":"2025","unstructured":"Patel RC, Thomas CD, Rossi JS, Franchi F, Keeley EC, Beitelshees AL, Duarte JD, Ortega-Paz L, Kulick N, Winget M, Nguyen AB, Yang WE, Venkatesh S, Angiolillo DJ, Cavallari LH, Lee CR, Stouffer GA (2025) CYP2C19 phenotype, P2Y inhibitor selection, and clinical outcomes in patients on maintenance clopidogrel therapy. J Am Heart Assoc 14(14):e041634. https:\/\/doi.org\/10.1161\/JAHA.125.041634","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"4352_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D\u2019Orazi G (2016) Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY) 8(4):603\u2013619. https:\/\/doi.org\/10.18632\/aging.100934","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"4352_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0022-3565(25)31704-0","volume":"210","author":"SW Rabkin","year":"1979","unstructured":"Rabkin SW, Friesen JM, Ferris JA, Fung HY (1979) A model of cardiac arrhythmias and sudden death: cantharidin-induced toxic cardiomyopathy. J Pharmacol Exp Ther 210(1):43\u201350","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"4352_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMoa052891","volume":"354","author":"G Remuzzi","year":"2006","unstructured":"Remuzzi G, Cravedi P, Perna A, Dimitrov BD, Turturro M, Locatelli G, Rigotti P, Baldan N, Beatini M, Valente U, Scalamogna M, Ruggenenti P, Dual Kidney Transplant Group (2006) Long-term outcome of renal transplantation from older donors. N Engl J Med 354(4):343\u2013352. https:\/\/doi.org\/10.1056\/NEJMoa052891","journal-title":"N Engl J Med"},{"issue":"4","key":"4352_CR31","first-page":"443","volume":"67","author":"G Rona","year":"1959","unstructured":"Rona G, Chappel CI, Balazs T, Gaudry R (1959) An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol 67(4):443\u2013455","journal-title":"AMA Arch Pathol"},{"key":"4352_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116020","volume":"170","author":"F Rostamzadeh","year":"2024","unstructured":"Rostamzadeh F, Najafipour H, Aminizadeh S, Jafari E (2024) Therapeutic effects of the combination of moderate-intensity endurance training and MitoQ supplementation in rats with isoproterenol-induced myocardial injury: the role of mitochondrial fusion, fission, and mitophagy. Biomed Pharmacother 170:116020. https:\/\/doi.org\/10.1016\/j.biopha.2023.116020","journal-title":"Biomed Pharmacother"},{"issue":"20","key":"4352_CR33","doi-asserted-by":"publisher","first-page":"10253","DOI":"10.1128\/JVI.01059-06","volume":"80","author":"B Sainz Jr","year":"2006","unstructured":"Sainz B Jr, Chisari FV (2006) Production of infectious Hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J Virol 80(20):10253\u201310257. https:\/\/doi.org\/10.1128\/JVI.01059-06","journal-title":"J Virol"},{"issue":"3","key":"4352_CR34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/s0008-6363(99)00384-3","volume":"45","author":"A Saraste","year":"2000","unstructured":"Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45(3):528\u2013537. https:\/\/doi.org\/10.1016\/s0008-6363(99)00384-3","journal-title":"Cardiovasc Res"},{"issue":"4","key":"4352_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1939-1676.1989.tb00859.x","volume":"3","author":"DG Schmitz","year":"1989","unstructured":"Schmitz DG (1989) Cantharidin toxicosis in horses. J Vet Intern Med 3(4):208\u2013215. https:\/\/doi.org\/10.1111\/j.1939-1676.1989.tb00859.x","journal-title":"J Vet Intern Med"},{"issue":"1","key":"4352_CR36","first-page":"3","volume":"77","author":"O Sezgin","year":"2014","unstructured":"Sezgin O, Barlas IO, U\u00e7bilek E, Yengel E, Altinta\u015f E (2014) Modified sequential Helicobacter pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser Turkish patients for CYP2C19 polymorphism is ineffective. Acta Gastroenterol Belg 77(1):3\u20137","journal-title":"Acta Gastroenterol Belg"},{"issue":"1","key":"4352_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-020-00449-8","volume":"21","author":"H Shao","year":"2020","unstructured":"Shao H, Dong L, Feng Y, Wang C, Tong H (2020) The protective effect of L-glutamine against acute Cantharidin-induced cardiotoxicity in the mice. BMC Pharmacol Toxicol 21(1):71. https:\/\/doi.org\/10.1186\/s40360-020-00449-8","journal-title":"BMC Pharmacol Toxicol"},{"issue":"3","key":"4352_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1124\/dmd.108.023416","volume":"37","author":"D Si","year":"2009","unstructured":"Si D, Wang Y, Zhou YH, Guo Y, Wang J, Zhou H, Li ZS, Fawcett JP (2009) Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab Dispos 37(3):629\u2013634. https:\/\/doi.org\/10.1124\/dmd.108.023416","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"4352_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clpt.2005.10.002","volume":"79","author":"SC Sim","year":"2006","unstructured":"Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L, Ingelman-Sundberg M (2006) A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther 79(1):103\u2013113. https:\/\/doi.org\/10.1016\/j.clpt.2005.10.002","journal-title":"Clin Pharmacol Ther"},{"key":"4352_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.108939","volume":"317","author":"M Song","year":"2020","unstructured":"Song M, Wang X, Luo Y, Liu Z, Tan W, Ye P, Fu Z, Lu F, Xiang W, Tang L, Yao L, Nie Y, Xiao J (2020) Cantharidin suppresses gastric cancer cell migration\/invasion by inhibiting the PI3K\/Akt signaling pathway via CCAT1. Chem Biol Interact 317:108939. https:\/\/doi.org\/10.1016\/j.cbi.2020.108939","journal-title":"Chem Biol Interact"},{"key":"4352_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jpba.2014.03.018","volume":"101","author":"D Spaggiari","year":"2014","unstructured":"Spaggiari D, Geiser L, Daali Y, Rudaz S (2014) A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies. J Pharm Biomed Anal 101:221\u2013237. https:\/\/doi.org\/10.1016\/j.jpba.2014.03.018","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"4352_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00134-008-1383-2","volume":"35","author":"I Spriet","year":"2009","unstructured":"Spriet I, Meersseman W, de Hoon J, von Winckelmann S, Wilmer A, Willems L (2009) Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU. Intensive Care Med 35(4):603\u2013612. https:\/\/doi.org\/10.1007\/s00134-008-1383-2","journal-title":"Intensive Care Med"},{"issue":"12","key":"4352_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.14348\/molcells.2016.0023","volume":"39","author":"X Sun","year":"2016","unstructured":"Sun X, Cai X, Yang J, Chen J, Guo C, Cao P (2016) Cantharidin overcomes Imatinib resistance by depleting BCR-ABL in chronic myeloid leukemia. Mol Cells 39(12):869\u2013876. https:\/\/doi.org\/10.14348\/molcells.2016.0023","journal-title":"Mol Cells"},{"key":"4352_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.apha.2018.04.007","volume":"83","author":"A Tornio","year":"2018","unstructured":"Tornio A, Backman JT (2018) Cytochrome P450 in pharmacogenetics: an update. Adv Pharmacol 83:3\u201332. https:\/\/doi.org\/10.1016\/bs.apha.2018.04.007","journal-title":"Adv Pharmacol"},{"issue":"3","key":"4352_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","volume":"108","author":"RA Totah","year":"2008","unstructured":"Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED (2008) Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology 108(3):363\u2013374. https:\/\/doi.org\/10.1097\/ALN.0b013e3181642938","journal-title":"Anesthesiology"},{"issue":"2","key":"4352_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0378-8741(89)90062-7","volume":"26","author":"GS Wang","year":"1989","unstructured":"Wang GS (1989) Medical uses of Mylabris in ancient China and recent studies. J Ethnopharmacol 26(2):147\u2013162. https:\/\/doi.org\/10.1016\/0378-8741(89)90062-7","journal-title":"J Ethnopharmacol"},{"issue":"17","key":"4352_CR47","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.2174\/0929867324666170414165253","volume":"25","author":"G Wang","year":"2018","unstructured":"Wang G, Dong J, Deng L (2018) Overview of Cantharidin and its analogues. Curr Med Chem 25(17):2034\u20132044. https:\/\/doi.org\/10.2174\/0929867324666170414165253","journal-title":"Curr Med Chem"},{"issue":"1","key":"4352_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-022-00602-x","volume":"14","author":"NN Wang","year":"2022","unstructured":"Wang NN, Wang XG, Xiong GL, Yang ZY, Lu AP, Chen X, Liu S, Hou TJ, Cao DS (2022) Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes. J Cheminform 14(1):23. https:\/\/doi.org\/10.1186\/s13321-022-00602-x","journal-title":"J Cheminform"},{"issue":"1","key":"4352_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-023-00710-2","volume":"18","author":"H Wang","year":"2023","unstructured":"Wang H, Wu Z, Fan X, Wu C, Lu S, Geng L, Stalin A, Zhu Y, Zhang F, Huang J, Liu P, Li H, You L, Wu J (2023) Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments. Chin Med 18(1):7. https:\/\/doi.org\/10.1186\/s13020-023-00710-2","journal-title":"Chin Med"},{"issue":"6","key":"4352_CR50","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/clpt.1984.256","volume":"36","author":"PJ Wedlund","year":"1984","unstructured":"Wedlund PJ, Aslanian WS, McAllister CB, Wilkinson GR, Branch RA (1984) Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism. Clin Pharmacol Ther 36(6):773\u2013780. https:\/\/doi.org\/10.1038\/clpt.1984.256","journal-title":"Clin Pharmacol Ther"},{"issue":"18","key":"4352_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.70088","volume":"39","author":"G Wei","year":"2025","unstructured":"Wei G, Li B, Wang H, Chen W, Chen K, Wang W, Wang S, Zeng H, Liu Y, Zeng Y, Rao H (2025) CYP2C19 loss-of-function is an independent risk factor of coronary artery disease in patients with hypertension. J Clin Lab Anal 39(18):e70088. https:\/\/doi.org\/10.1002\/jcla.70088","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"4352_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11040234","volume":"11","author":"DW Whitman","year":"2019","unstructured":"Whitman DW, Andr\u00e9s MF, Mart\u00ednez-D\u00edaz RA, Ib\u00e1\u00f1ez-Escribano A, Olmeda AS, Gonz\u00e1lez-Coloma A (2019) Antiparasitic properties of Cantharidin and the blister beetle Berberomeloe majalis (Coleoptera: Meloidae). Toxins (Basel) 11(4):234. https:\/\/doi.org\/10.3390\/toxins11040234","journal-title":"Toxins (Basel)"},{"issue":"3","key":"4352_CR53","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1021\/acs.jmedchem.9b02067","volume":"63","author":"WC Wright","year":"2020","unstructured":"Wright WC, Chenge J, Wang J, Girvan HM, Yang L, Chai SC, Huber AD, Wu J, Oladimeji PO, Munro AW, Chen T (2020) Clobetasol propionate is a heme-mediated selective inhibitor of human cytochrome P450 3A5. J Med Chem 63(3):1415\u20131433. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b02067","journal-title":"J Med Chem"},{"issue":"2","key":"4352_CR54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00008571-199704000-00004","volume":"7","author":"HG Xie","year":"1997","unstructured":"Xie HG, Huang SL, Xu ZH, Xiao ZS, He N, Zhou HH (1997) Evidence for the effect of gender on activity of (S)-mephenytoin 4\u2019-hydroxylase (CYP2C19) in a Chinese population. Pharmacogenetics 7(2):115\u2013119. https:\/\/doi.org\/10.1097\/00008571-199704000-00004","journal-title":"Pharmacogenetics"},{"issue":"6","key":"4352_CR55","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3892\/mmr.2014.2107","volume":"9","author":"BS Xie","year":"2014","unstructured":"Xie BS, He XX, Ai ZL, Yao SK (2014) Involvement of \u03b2-catenin in matrine-induced autophagy and apoptosis in WB-F344 cells. Mol Med Rep 9(6):2547\u20132553. https:\/\/doi.org\/10.3892\/mmr.2014.2107","journal-title":"Mol Med Rep"},{"issue":"2","key":"4352_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1365-2125.2011.04076.x","volume":"73","author":"J Yang","year":"2012","unstructured":"Yang J, He MM, Niu W, Wrighton SA, Li L, Liu Y, Li C (2012) Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes. Br J Clin Pharmacol 73(2):268\u2013284. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04076.x","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"4352_CR57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/cvr\/cvab013","volume":"118","author":"Y Yao","year":"2022","unstructured":"Yao Y, Song Q, Hu C, Da X, Yu Y, He Z, Xu C, Chen Q, Wang QK (2022) Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes. Cardiovasc Res 118(1):196\u2013211. https:\/\/doi.org\/10.1093\/cvr\/cvab013","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4352_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138(1):103\u2013141. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.12.007","journal-title":"Pharmacol Ther"},{"key":"4352_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.yrtph.2018.05.007","volume":"96","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhou X, Zhang J, Guan C, Liu L (2018) Cantharides poisoning: a retrospective analysis from 1996 to 2016 in China. Regul Toxicol Pharmacol 96:142\u2013145. https:\/\/doi.org\/10.1016\/j.yrtph.2018.05.007","journal-title":"Regul Toxicol Pharmacol"},{"key":"4352_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108780","volume":"113","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang L, Fan X, Yang W, Yu B, Kou J, Li F (2019) Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a\/\u03b2-catenin and Jak2\/Stat3 pathways. Biomed Pharmacother 113:108780. https:\/\/doi.org\/10.1016\/j.biopha.2019.108780","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"4352_CR61","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/jat.4000","volume":"40","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Liu L, Ren L (2020) RNA-sequencing-based transcriptome analysis of cantharidin-induced myocardial injury. J Appl Toxicol 40(11):1491\u20131497. https:\/\/doi.org\/10.1002\/jat.4000","journal-title":"J Appl Toxicol"},{"key":"4352_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1644186","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, Tian T, Li C, Liu Y, Wang Y, Liu L, Liu L, Yao Y (2025) Cantharidin: a double-edged sword in medicine and toxicology. Front Pharmacol 16:1644186. https:\/\/doi.org\/10.3389\/fphar.2025.1644186","journal-title":"Front Pharmacol"},{"issue":"7","key":"4352_CR63","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1211\/002235702760089135","volume":"54","author":"S Zhou","year":"2002","unstructured":"Zhou S, Kestell P, Paxton JW (2002) Non-specific binding of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in liver microsomes from various species. J Pharm Pharmacol 54(7):997\u20131003. https:\/\/doi.org\/10.1211\/002235702760089135","journal-title":"J Pharm Pharmacol"},{"key":"4352_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.fitote.2015.10.008","volume":"107","author":"CJ Zhou","year":"2015","unstructured":"Zhou CJ, Qiao LM, Zhao LH, Li ZY (2015) Evaluation of the impact of cantharidin on rat CYP enzymes by using a cocktail of probe drugs. Fitoterapia 107:49\u201353. https:\/\/doi.org\/10.1016\/j.fitote.2015.10.008","journal-title":"Fitoterapia"},{"key":"4352_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177927","volume":"1003","author":"L Zhou","year":"2025","unstructured":"Zhou L, Zhao P, Zhou T, Chen M, Feng Z, Pan Y, Xiao F, Hao X, Song H, Yang J (2025) Cantharidin induces pyroptosis in triple-negative breast cancer cells via Vitamin D receptor-targeted inhibition and activation of ROS\/caspase\/GSDME axis. Eur J Pharmacol 1003:177927. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177927","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"4352_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009099","volume":"12","author":"M Zhu","year":"2024","unstructured":"Zhu M, Tang W, Tang X, Zhu Z, Jiang Y, Sarwar A, Zhang H, Chu D, Zhang Z, Zhang Y (2024) Cantharidin overcomes IL-2R\u03b1 signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species. J Immunother Cancer 12(7):e009099. https:\/\/doi.org\/10.1136\/jitc-2024-009099","journal-title":"J Immunother Cancer"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04352-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04352-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04352-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T10:02:50Z","timestamp":1782554570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04352-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4352"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04352-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}